Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome

<p dir="ltr">Cardiogenic shock (CS) is a hemodynamically complex and highly morbid syndrome characterized by circulatory collapse and inadequate end-organ perfusion due to impaired cardiac output. It is usually associated with multiorgan failure and death. Mortality rate is still hig...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Rasha Kaddoura (12506936) (author)
مؤلفون آخرون: Salah Elbdri (16400074) (author)
منشور في: 2021
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513549553893376
author Rasha Kaddoura (12506936)
author2 Salah Elbdri (16400074)
author2_role author
author_facet Rasha Kaddoura (12506936)
Salah Elbdri (16400074)
author_role author
dc.creator.none.fl_str_mv Rasha Kaddoura (12506936)
Salah Elbdri (16400074)
dc.date.none.fl_str_mv 2021-09-24T09:00:00Z
dc.identifier.none.fl_str_mv 10.31083/j.rcm2203078
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Current_evidence_in_the_diagnosis_and_management_of_cardiogenic_shock_complicating_acute_coronary_syndrome/28937633
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Acute myocardial infarction
Cardiogenic shock
Inotrope
Mechanical circulatory support
Pulmonary artery catheter
Vasopressor
dc.title.none.fl_str_mv Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Cardiogenic shock (CS) is a hemodynamically complex and highly morbid syndrome characterized by circulatory collapse and inadequate end-organ perfusion due to impaired cardiac output. It is usually associated with multiorgan failure and death. Mortality rate is still high despite advancement in treatment. CS has been conceptualised as a vicious cycle of injury and decompensation, both cardiac and systemic. Interrupting the vicious cycle and restoring the hemodynamic stability is a fundamental treatment of CS. Acute coronary syndrome (ACS) is the most frequent cause of CS. Early coronary revascularization is a cornerstone therapy that reduces mortality in patients with ACS complicated by CS. Early diagnosis of CS accompanied with invasive hemodynamics, helps in identification of CS phenotype, classification of CS severity, stratification of risk and prognostication. This can guide a tailored and optimized therapeutic approach. Inotropes and vasopressors are considered the first-line pharmacological option for hemodynamic instability. The current availability of the mechanical circulatory support devices has broadened the therapeutic choices for hemodynamic support. To date there is no pharmacological or nonpharmacological intervention for CS that showed a mortality benefit. The clinical practices in CS management remain inconsistent. Herein, this review discusses the current evidence in the diagnosis and management of CS complicating ACS, and features the changes in CS definition and classification.</p><h2>Other Information</h2><p dir="ltr">Published in: Reviews in Cardiovascular Medicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.31083/j.rcm2203078" target="_blank">https://dx.doi.org/10.31083/j.rcm2203078</a></p>
eu_rights_str_mv openAccess
id Manara2_b059286040eba73ac6681188d8f2762d
identifier_str_mv 10.31083/j.rcm2203078
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/28937633
publishDate 2021
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndromeRasha Kaddoura (12506936)Salah Elbdri (16400074)Biomedical and clinical sciencesCardiovascular medicine and haematologyAcute myocardial infarctionCardiogenic shockInotropeMechanical circulatory supportPulmonary artery catheterVasopressor<p dir="ltr">Cardiogenic shock (CS) is a hemodynamically complex and highly morbid syndrome characterized by circulatory collapse and inadequate end-organ perfusion due to impaired cardiac output. It is usually associated with multiorgan failure and death. Mortality rate is still high despite advancement in treatment. CS has been conceptualised as a vicious cycle of injury and decompensation, both cardiac and systemic. Interrupting the vicious cycle and restoring the hemodynamic stability is a fundamental treatment of CS. Acute coronary syndrome (ACS) is the most frequent cause of CS. Early coronary revascularization is a cornerstone therapy that reduces mortality in patients with ACS complicated by CS. Early diagnosis of CS accompanied with invasive hemodynamics, helps in identification of CS phenotype, classification of CS severity, stratification of risk and prognostication. This can guide a tailored and optimized therapeutic approach. Inotropes and vasopressors are considered the first-line pharmacological option for hemodynamic instability. The current availability of the mechanical circulatory support devices has broadened the therapeutic choices for hemodynamic support. To date there is no pharmacological or nonpharmacological intervention for CS that showed a mortality benefit. The clinical practices in CS management remain inconsistent. Herein, this review discusses the current evidence in the diagnosis and management of CS complicating ACS, and features the changes in CS definition and classification.</p><h2>Other Information</h2><p dir="ltr">Published in: Reviews in Cardiovascular Medicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.31083/j.rcm2203078" target="_blank">https://dx.doi.org/10.31083/j.rcm2203078</a></p>2021-09-24T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.31083/j.rcm2203078https://figshare.com/articles/journal_contribution/Current_evidence_in_the_diagnosis_and_management_of_cardiogenic_shock_complicating_acute_coronary_syndrome/28937633CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/289376332021-09-24T09:00:00Z
spellingShingle Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
Rasha Kaddoura (12506936)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Acute myocardial infarction
Cardiogenic shock
Inotrope
Mechanical circulatory support
Pulmonary artery catheter
Vasopressor
status_str publishedVersion
title Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
title_full Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
title_fullStr Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
title_full_unstemmed Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
title_short Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
title_sort Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Acute myocardial infarction
Cardiogenic shock
Inotrope
Mechanical circulatory support
Pulmonary artery catheter
Vasopressor